Immunoregulatory mechanisms underlying prevention of colitis-associated colorectal cancer by probiotic bacteria
about
Modeling-Enabled Systems Nutritional ImmunologyMetabiotics: One Step ahead of Probiotics; an Insight into Mechanisms Involved in Anticancerous Effect in Colorectal CancerModulation of immunity and inflammatory gene expression in the gut, in inflammatory diseases of the gut and in the liver by probiotics.Molecular dialogue between the human gut microbiota and the host: a Lactobacillus and Bifidobacterium perspective.Predictive computational modeling of the mucosal immune responses during Helicobacter pylori infectionVSL#3 probiotic modifies mucosal microbial composition but does not reduce colitis-associated colorectal cancer.Small molecule immunomodulins from cultures of the human microbiome member Lactobacillus plantarum.The multifaceted role of commensal microbiota in homeostasis and gastrointestinal diseases.Colorectal cancer in patients with inflammatory bowel disease: can we predict risk?Kluyveromyces marxianus and Saccharomyces boulardii Induce Distinct Levels of Dendritic Cell Cytokine Secretion and Significantly Different T Cell Responses In Vitro.Nutritional modulators of ulcerative colitis: clinical efficacies and mechanistic viewDiet and nutrition in cancer survivorship and palliative care.The new prophylactic strategy for colon cancer in inflammatory bowel disease by modulating microbiota.Current issues in inflammatory bowel disease neoplasia.Evolving Roles of Probiotics in Cancer Prophylaxis and Therapy.The Potential Role of Probiotics in Cancer Prevention and Treatment.Short Chain and Polyunsaturated Fatty Acids in Host Gut Health and Foodborne Bacterial Pathogen Inhibition.PPARγ in Inflammatory Bowel Disease.Proteus mirabilis inhibits cancer growth and pulmonary metastasis in a mouse breast cancer model.Probiotic Strain Lactobacillus casei BL23 Prevents Colitis-Associated Colorectal Cancer.Development of a potential probiotic yoghurt using selected anti-inflammatory lactic acid bacteria for prevention of colitis and carcinogenesis in mice.Pretreatment with probiotic Bifico ameliorates colitis-associated cancer in mice: Transcriptome and gut flora profiling.The Probiotic VSL#3 Modulates Colonic Macrophages, Inflammation, and Microflora in Acute Trinitrobenzene Sulfonic Acid Colitis.Effect of Conjugated Linoleic Acid-enriched Butter After 24 hours of Intestinal Mucositis Induction.Inhibition of chronic ulcerative colitis-associated adenocarcinoma development in mice by VSL#3.Cyclooxygenase as a target in chemoprevention by probiotics during 1,2-dimethylhydrazine induced colon carcinogenesis in rats.Colorectal Cancer Cells Increase the Production of Short Chain Fatty Acids by Propionibacterium freudenreichii Impacting on Cancer Cells Survival.VSL#3 can prevent ulcerative colitis-associated carcinogenesis in mice
P2860
Q26766623-47367790-FC64-4271-8CF9-E332473DB27AQ28077783-B3D945C0-2728-46EB-8289-342A3C1A45EDQ34499067-069462BF-E900-4A8C-A418-3AEF52ACBE9BQ34629039-CE962901-88F9-42AE-B2F9-E4BAFEF2FD50Q34988965-BDAD9EAE-6174-4664-8045-89A4EC30C3D9Q35010644-B3AC6359-F030-41FE-8EA6-3CA24990ABFFQ35054819-7805A8D1-1CFD-4FDA-95BA-19CCFC71CAAFQ35156014-761EE947-E6FF-45B9-81FB-D191F48646F2Q36175033-3C4D9372-02C4-4977-8D0C-15E59C6C2B54Q36206938-3210185B-ECA7-4E4B-BB88-949AF90F47D0Q36637753-656AED57-E127-4877-845C-03A13BC7FDB6Q37322307-8644235B-66C8-4A7F-8E1E-6E05C8BEF1C1Q38068230-9DB1925B-14F3-4488-A949-B37C5C3A4928Q38255045-8133609D-EA46-47B1-802E-AB47B0A85A56Q38702152-1F2CCC40-FA69-494B-886B-42D1FB468C3AQ38825153-E030B11F-4F02-4758-9FE2-F170DE1150A8Q38903226-D77633D2-D220-4CA3-8F51-4105D49AC819Q42038488-BE4198CF-480A-4026-B74F-9772404AE9ABQ46247736-136E1BD2-F975-49A1-860E-FCF6C3FEB783Q47151578-0AF6F247-9F42-426A-956F-4F37A6DAAF5FQ48186544-0CE1EA99-1E9F-435D-8E43-C45435DA8E35Q49483670-A1DCC657-CB9D-4E5B-A578-0D1E9BEAA108Q50899710-7908378E-3FBF-437D-ABB1-279BFC519B1EQ53020267-4F780C67-1563-439C-9BC2-A55D21087084Q53575927-3E86414F-D7BC-4EE4-A302-1551854FBAE4Q54460901-CCB6D0AE-6FFA-438B-9C78-2F39ED7B2E1BQ55006948-0BDDB956-33DC-4C75-A144-3180F6B81D55Q57482205-03E8308B-62D5-4B1C-A6F5-A9800EB6296E
P2860
Immunoregulatory mechanisms underlying prevention of colitis-associated colorectal cancer by probiotic bacteria
description
2012 թուականին հրատարակուած գիտական յօդուած
@hyw
2012 թվականին հրատարակված գիտական հոդված
@hy
artículu científicu espublizáu en 2012
@ast
im Januar 2012 veröffentlichter wissenschaftlicher Artikel
@de
scientific article (publication date: 2012)
@en
vedecký článok (publikovaný 2012)
@sk
vědecký článek publikovaný v roce 2012
@cs
wetenschappelijk artikel (gepubliceerd in 2012)
@nl
наукова стаття, опублікована у 2012
@uk
مقالة علمية (نشرت عام 2012)
@ar
name
Immunoregulatory mechanisms un ...... l cancer by probiotic bacteria
@ast
Immunoregulatory mechanisms un ...... l cancer by probiotic bacteria
@en
Immunoregulatory mechanisms un ...... l cancer by probiotic bacteria
@nl
type
label
Immunoregulatory mechanisms un ...... l cancer by probiotic bacteria
@ast
Immunoregulatory mechanisms un ...... l cancer by probiotic bacteria
@en
Immunoregulatory mechanisms un ...... l cancer by probiotic bacteria
@nl
prefLabel
Immunoregulatory mechanisms un ...... l cancer by probiotic bacteria
@ast
Immunoregulatory mechanisms un ...... l cancer by probiotic bacteria
@en
Immunoregulatory mechanisms un ...... l cancer by probiotic bacteria
@nl
P2860
P50
P1433
P1476
Immunoregulatory mechanisms un ...... l cancer by probiotic bacteria
@en
P2093
Claudio De Simone
P2860
P304
P356
10.1371/JOURNAL.PONE.0034676
P407
P577
2012-01-01T00:00:00Z